| |
| |
|
| Insider
Information: |
Schulman Amy W |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
497,497 |
|
|
Indirect Shares
|
3,032,347 |
|
|
| Direct
Value |
$8,747,740 |
|
|
|
Indirect Value
|
$104,619 |
|
|
| Total
Shares |
3,529,844 |
|
|
| Total
Value |
$8,852,358 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pfizer Inc |
PFE |
Executive Vice President |
2013-05-15 |
223,497 |
2013-05-15 |
3,506 |
Premium* |
|
|
Zoetis Inc. |
ZTS |
Director |
2013-02-06 |
5,000 |
2013-02-06 |
0 |
Premium* |
|
|
Ironwood Pharmaceuticals Inc |
IRWD |
Director |
2019-04-01 |
38,242 |
2017-01-01 |
0 |
Premium* |
|
|
Cyclerion Therapeutics, Inc. |
CYCN |
Director |
2019-04-08 |
7,508 |
2019-04-08 |
21,635 |
Premium* |
|
|
Sqz Biotechnologies Co |
SQZ |
Director, 10% Owner |
2021-12-22 |
214,814 |
2021-12-22 |
3,007,206 |
Premium* |
|
|
Alnylam Pharmaceuticals Inc |
ALNY |
Director |
2024-05-29 |
8,436 |
2023-02-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
35 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PFE |
Pfizer Inc |
Executive Vice President |
• – – |
2012-02-24 |
4 |
D |
$21.18 |
$402,208 |
D/D |
(18,990) |
242,358 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2013-02-28 |
4 |
D |
$27.37 |
$556,596 |
D/D |
(20,336) |
292,167 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• – – |
2011-06-30 |
4 |
D |
$20.60 |
$1,191,998 |
D/D |
(57,864) |
186,636 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2012-12-06 |
4 |
OE |
$17.47 |
$1,747,000 |
D/D |
100,000 |
346,656 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2024-05-29 |
4 |
OE |
$66.83 |
$2,004,900 |
D/D |
30,000 |
30,136 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2013-05-15 |
4 |
AS |
$29.29 |
$2,055,389 |
D/D |
(70,000) |
223,497 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2012-12-06 |
4 |
S |
$25.56 |
$2,555,930 |
D/D |
(100,000) |
246,656 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2024-05-29 |
4 |
AS |
$148.21 |
$3,224,546 |
D/D |
(21,700) |
8,436 |
0 |
% |
|
| SQZ |
Sqz Biotechnologies Co |
Director |
– • • |
2020-11-03 |
4 |
B |
$16.00 |
$4,000,000 |
I/I |
250,000 |
2,549,306 |
2.25 |
- |
|
| CYCN |
Cyclerion Therapeutics, I... |
Director |
– • – |
2019-04-08 |
4 |
B |
$16.00 |
$10,017,872 |
I/I |
626,117 |
21,635 |
2.1 |
- |
|
35 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
